Scientific advances in lung cancer 2015

Anne S. Tsao, Giorgio V. Scagliotti, Paul A. Bunn, David P. Carbone, Graham W. Warren, Chunxue Bai, Harry J. De Koning, A. Uraujh Yousaf-Khan, Annette McWilliams, Ming Sound Tsao, Prasad S. Adusumilli, Ramón Rami-Porta, Hisao Asamura, Paul E. Van Schil, Gail E. Darling, Suresh S. Ramalingam, Daniel R. Gomez, Kenneth E. Rosenzweig, Stefan Zimmermann, Solange PetersSai Hong Ignatius Ou, Thanyanan Reungwetwattana, Pasi A. Jänne, Tony S. Mok, Heather A. Wakelee, Robert Pirker, Julien Mazières, Julie R. Brahmer, Yang Zhou, Roy S. Herbst, Vassiliki A. Papadimitrakopoulou, Mary W. Redman, Murry W. Wynes, David R. Gandara, Ronan J. Kelly, Fred R. Hirsch, Harvey I. Pass

Research output: Contribution to journalReview article

109 Citations (Scopus)

Abstract

Lung cancer continues to be a major global health problem; the disease is diagnosed in more than 1.6 million new patients each year. However, significant progress is underway in both the prevention and treatment of lung cancer. Lung cancer therapy has now emerged as a "role model" for precision cancer medicine, with several important therapeutic breakthroughs occurring during 2015. These advances have occurred primarily in the immunotherapy field and in treatments directed against tumors harboring specific oncogenic drivers. Our knowledge about molecular mechanisms for oncogene-driven tumors and about resistance to targeted therapies has increased quickly over the past year. As a result, several regulatory approvals of new agents that significantly improve survival and quality of life for patients with lung cancer who have advanced disease have occurred. The International Association for the Study of Lung Cancer has gathered experts in different areas of lung cancer research and management to summarize the most significant scientific advancements related to prevention and therapy of lung cancer during the past year.

Original languageEnglish
Pages (from-to)613-638
Number of pages26
JournalJournal of Thoracic Oncology
Volume11
Issue number5
DOIs
Publication statusPublished - 2016

Fingerprint

Lung Neoplasms
Therapeutics
Neoplasms
Precision Medicine
Oncogenes
Immunotherapy
Quality of Life
Survival
Research

Keywords

  • Adjuvant chemotherapy
  • Biomarkers
  • Cancer prevention
  • Gene mutations
  • Immunotherapy
  • Lung cancer
  • Master protocols
  • Pathology
  • Radiotherapy
  • Screening
  • Smoking cessation
  • Staging
  • Surgery
  • Targeted therapy
  • Value of therapy

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Tsao, A. S., Scagliotti, G. V., Bunn, P. A., Carbone, D. P., Warren, G. W., Bai, C., ... Pass, H. I. (2016). Scientific advances in lung cancer 2015. Journal of Thoracic Oncology, 11(5), 613-638. https://doi.org/10.1016/j.jtho.2016.03.012

Scientific advances in lung cancer 2015. / Tsao, Anne S.; Scagliotti, Giorgio V.; Bunn, Paul A.; Carbone, David P.; Warren, Graham W.; Bai, Chunxue; De Koning, Harry J.; Uraujh Yousaf-Khan, A.; McWilliams, Annette; Tsao, Ming Sound; Adusumilli, Prasad S.; Rami-Porta, Ramón; Asamura, Hisao; Van Schil, Paul E.; Darling, Gail E.; Ramalingam, Suresh S.; Gomez, Daniel R.; Rosenzweig, Kenneth E.; Zimmermann, Stefan; Peters, Solange; Ou, Sai Hong Ignatius; Reungwetwattana, Thanyanan; Jänne, Pasi A.; Mok, Tony S.; Wakelee, Heather A.; Pirker, Robert; Mazières, Julien; Brahmer, Julie R.; Zhou, Yang; Herbst, Roy S.; Papadimitrakopoulou, Vassiliki A.; Redman, Mary W.; Wynes, Murry W.; Gandara, David R.; Kelly, Ronan J.; Hirsch, Fred R.; Pass, Harvey I.

In: Journal of Thoracic Oncology, Vol. 11, No. 5, 2016, p. 613-638.

Research output: Contribution to journalReview article

Tsao, AS, Scagliotti, GV, Bunn, PA, Carbone, DP, Warren, GW, Bai, C, De Koning, HJ, Uraujh Yousaf-Khan, A, McWilliams, A, Tsao, MS, Adusumilli, PS, Rami-Porta, R, Asamura, H, Van Schil, PE, Darling, GE, Ramalingam, SS, Gomez, DR, Rosenzweig, KE, Zimmermann, S, Peters, S, Ou, SHI, Reungwetwattana, T, Jänne, PA, Mok, TS, Wakelee, HA, Pirker, R, Mazières, J, Brahmer, JR, Zhou, Y, Herbst, RS, Papadimitrakopoulou, VA, Redman, MW, Wynes, MW, Gandara, DR, Kelly, RJ, Hirsch, FR & Pass, HI 2016, 'Scientific advances in lung cancer 2015', Journal of Thoracic Oncology, vol. 11, no. 5, pp. 613-638. https://doi.org/10.1016/j.jtho.2016.03.012
Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C et al. Scientific advances in lung cancer 2015. Journal of Thoracic Oncology. 2016;11(5):613-638. https://doi.org/10.1016/j.jtho.2016.03.012
Tsao, Anne S. ; Scagliotti, Giorgio V. ; Bunn, Paul A. ; Carbone, David P. ; Warren, Graham W. ; Bai, Chunxue ; De Koning, Harry J. ; Uraujh Yousaf-Khan, A. ; McWilliams, Annette ; Tsao, Ming Sound ; Adusumilli, Prasad S. ; Rami-Porta, Ramón ; Asamura, Hisao ; Van Schil, Paul E. ; Darling, Gail E. ; Ramalingam, Suresh S. ; Gomez, Daniel R. ; Rosenzweig, Kenneth E. ; Zimmermann, Stefan ; Peters, Solange ; Ou, Sai Hong Ignatius ; Reungwetwattana, Thanyanan ; Jänne, Pasi A. ; Mok, Tony S. ; Wakelee, Heather A. ; Pirker, Robert ; Mazières, Julien ; Brahmer, Julie R. ; Zhou, Yang ; Herbst, Roy S. ; Papadimitrakopoulou, Vassiliki A. ; Redman, Mary W. ; Wynes, Murry W. ; Gandara, David R. ; Kelly, Ronan J. ; Hirsch, Fred R. ; Pass, Harvey I. / Scientific advances in lung cancer 2015. In: Journal of Thoracic Oncology. 2016 ; Vol. 11, No. 5. pp. 613-638.
@article{65880e14834349aab5310dc117b81fce,
title = "Scientific advances in lung cancer 2015",
abstract = "Lung cancer continues to be a major global health problem; the disease is diagnosed in more than 1.6 million new patients each year. However, significant progress is underway in both the prevention and treatment of lung cancer. Lung cancer therapy has now emerged as a {"}role model{"} for precision cancer medicine, with several important therapeutic breakthroughs occurring during 2015. These advances have occurred primarily in the immunotherapy field and in treatments directed against tumors harboring specific oncogenic drivers. Our knowledge about molecular mechanisms for oncogene-driven tumors and about resistance to targeted therapies has increased quickly over the past year. As a result, several regulatory approvals of new agents that significantly improve survival and quality of life for patients with lung cancer who have advanced disease have occurred. The International Association for the Study of Lung Cancer has gathered experts in different areas of lung cancer research and management to summarize the most significant scientific advancements related to prevention and therapy of lung cancer during the past year.",
keywords = "Adjuvant chemotherapy, Biomarkers, Cancer prevention, Gene mutations, Immunotherapy, Lung cancer, Master protocols, Pathology, Radiotherapy, Screening, Smoking cessation, Staging, Surgery, Targeted therapy, Value of therapy",
author = "Tsao, {Anne S.} and Scagliotti, {Giorgio V.} and Bunn, {Paul A.} and Carbone, {David P.} and Warren, {Graham W.} and Chunxue Bai and {De Koning}, {Harry J.} and {Uraujh Yousaf-Khan}, A. and Annette McWilliams and Tsao, {Ming Sound} and Adusumilli, {Prasad S.} and Ram{\'o}n Rami-Porta and Hisao Asamura and {Van Schil}, {Paul E.} and Darling, {Gail E.} and Ramalingam, {Suresh S.} and Gomez, {Daniel R.} and Rosenzweig, {Kenneth E.} and Stefan Zimmermann and Solange Peters and Ou, {Sai Hong Ignatius} and Thanyanan Reungwetwattana and J{\"a}nne, {Pasi A.} and Mok, {Tony S.} and Wakelee, {Heather A.} and Robert Pirker and Julien Mazi{\`e}res and Brahmer, {Julie R.} and Yang Zhou and Herbst, {Roy S.} and Papadimitrakopoulou, {Vassiliki A.} and Redman, {Mary W.} and Wynes, {Murry W.} and Gandara, {David R.} and Kelly, {Ronan J.} and Hirsch, {Fred R.} and Pass, {Harvey I.}",
year = "2016",
doi = "10.1016/j.jtho.2016.03.012",
language = "English",
volume = "11",
pages = "613--638",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "5",

}

TY - JOUR

T1 - Scientific advances in lung cancer 2015

AU - Tsao, Anne S.

AU - Scagliotti, Giorgio V.

AU - Bunn, Paul A.

AU - Carbone, David P.

AU - Warren, Graham W.

AU - Bai, Chunxue

AU - De Koning, Harry J.

AU - Uraujh Yousaf-Khan, A.

AU - McWilliams, Annette

AU - Tsao, Ming Sound

AU - Adusumilli, Prasad S.

AU - Rami-Porta, Ramón

AU - Asamura, Hisao

AU - Van Schil, Paul E.

AU - Darling, Gail E.

AU - Ramalingam, Suresh S.

AU - Gomez, Daniel R.

AU - Rosenzweig, Kenneth E.

AU - Zimmermann, Stefan

AU - Peters, Solange

AU - Ou, Sai Hong Ignatius

AU - Reungwetwattana, Thanyanan

AU - Jänne, Pasi A.

AU - Mok, Tony S.

AU - Wakelee, Heather A.

AU - Pirker, Robert

AU - Mazières, Julien

AU - Brahmer, Julie R.

AU - Zhou, Yang

AU - Herbst, Roy S.

AU - Papadimitrakopoulou, Vassiliki A.

AU - Redman, Mary W.

AU - Wynes, Murry W.

AU - Gandara, David R.

AU - Kelly, Ronan J.

AU - Hirsch, Fred R.

AU - Pass, Harvey I.

PY - 2016

Y1 - 2016

N2 - Lung cancer continues to be a major global health problem; the disease is diagnosed in more than 1.6 million new patients each year. However, significant progress is underway in both the prevention and treatment of lung cancer. Lung cancer therapy has now emerged as a "role model" for precision cancer medicine, with several important therapeutic breakthroughs occurring during 2015. These advances have occurred primarily in the immunotherapy field and in treatments directed against tumors harboring specific oncogenic drivers. Our knowledge about molecular mechanisms for oncogene-driven tumors and about resistance to targeted therapies has increased quickly over the past year. As a result, several regulatory approvals of new agents that significantly improve survival and quality of life for patients with lung cancer who have advanced disease have occurred. The International Association for the Study of Lung Cancer has gathered experts in different areas of lung cancer research and management to summarize the most significant scientific advancements related to prevention and therapy of lung cancer during the past year.

AB - Lung cancer continues to be a major global health problem; the disease is diagnosed in more than 1.6 million new patients each year. However, significant progress is underway in both the prevention and treatment of lung cancer. Lung cancer therapy has now emerged as a "role model" for precision cancer medicine, with several important therapeutic breakthroughs occurring during 2015. These advances have occurred primarily in the immunotherapy field and in treatments directed against tumors harboring specific oncogenic drivers. Our knowledge about molecular mechanisms for oncogene-driven tumors and about resistance to targeted therapies has increased quickly over the past year. As a result, several regulatory approvals of new agents that significantly improve survival and quality of life for patients with lung cancer who have advanced disease have occurred. The International Association for the Study of Lung Cancer has gathered experts in different areas of lung cancer research and management to summarize the most significant scientific advancements related to prevention and therapy of lung cancer during the past year.

KW - Adjuvant chemotherapy

KW - Biomarkers

KW - Cancer prevention

KW - Gene mutations

KW - Immunotherapy

KW - Lung cancer

KW - Master protocols

KW - Pathology

KW - Radiotherapy

KW - Screening

KW - Smoking cessation

KW - Staging

KW - Surgery

KW - Targeted therapy

KW - Value of therapy

UR - http://www.scopus.com/inward/record.url?scp=84969833490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969833490&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2016.03.012

DO - 10.1016/j.jtho.2016.03.012

M3 - Review article

C2 - 27013409

AN - SCOPUS:84969833490

VL - 11

SP - 613

EP - 638

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 5

ER -